10:24:36 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-03-06 Halvårsrapport
2024-11-11 X-dag ordinarie utdelning HEALTH 0.00 EUR
2024-11-08 Årsstämma
2024-09-20 Bokslutskommuniké 2024
2024-03-07 Halvårsrapport
2023-11-17 X-dag ordinarie utdelning HEALTH 0.00 EUR
2023-11-16 Årsstämma
2023-09-28 Bokslutskommuniké 2023
2023-04-24 Extra Bolagsstämma 2023
2023-03-23 Halvårsrapport
2022-11-17 Årsstämma
2022-10-25 X-dag ordinarie utdelning HEALTH 0.00 EUR
2022-09-29 Bokslutskommuniké 2022
2022-06-29 Extra Bolagsstämma 2022
2022-02-24 Halvårsrapport
2021-10-29 X-dag ordinarie utdelning HEALTH 0.00 EUR
2021-10-28 Årsstämma
2021-09-15 Bokslutskommuniké 2021

Beskrivning

LandFinland
ListaFirst North Finland
SektorHälsovård
IndustriMedicinteknik
Nightingale Health är verksamt inom medicinteknik. Bolaget är specialiserat inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar plattformar och tjänster inom blodanalyser som används i sjukdomsförebyggande syfte. Utöver huvudverksamheten erbjuds även service och tillhörande kringtjänster. Verksamheten drivs globalt med störst närvaro inom Europa.
2022-11-29 08:45:00

Nightingale Health Plc - Managers' transactions - 29 November 2022 9:45 a.m. (EET)

____________________________________________

Person subject to the notification requirement

Name: Kaikarhenni Oy

Position: Member of the Board/Deputy member

(X) Legal person

(1):Person Discharging Managerial Responsibilities In Issuer

Name: Leena Niemistö

Position: Member of the Board

Issuer: Nightingale Health Plc

LEI: 743700WUIPC24LVMLO66

Notification type: INITIAL NOTIFICATION

Reference number: 21425/4/5

____________________________________________

Transaction date: 2022-11-25

Venue: FIRST NORTH GROWTH MARKET FINLAND (FSME)

Instrument type: SHARE

ISIN: FI4000490875

Nature of the transaction: ACQUISITION

(X) Executed under portfolio or asset management

Transaction details

(1): Volume: 74,074 Unit price: 1.164 EUR

Aggregated transactions

(1): Volume: 74,074 Volume weighted average price: 1.164 EUR

The purpose of the transaction

Board member Leena Niemistö transferred 74,074 series B shares held by her in Nightingale Health Plc to Kaikarhenni Oy, a company under her control.

For further information, please contact:

Teemu Suna, CEO
ir@nightingalehealth.com,tel. +358 20 730 1810

Certified Adviser:
Oaklins Merasco Ltd, tel. +358 9 6129 670

About Nightingale Health

Nightingale Health is The Preventative Health Company. Staying healthy is one of the top priorities in human life. Our health has a profound impact on our quality of life, and it's also strongly connected to the lives of those close to us. Nightingale Health enables prevention by combining the power of our in-house developed, advanced blood analysis technology with unprecedented access to global health repositories and world-leading medical research. With this combination, we go beyond the traditional healthcare and wellbeing tools: We provide the scientific connection to multiple health and disease outcomes and the ability to predict future healthy years.